Mexico's inflation exceeds expectations in 1st half of April    Egypt's gold prices slightly down on Wednesday    Tesla to incur $350m in layoff expenses in Q2    GAFI empowers entrepreneurs, startups in collaboration with African Development Bank    Egyptian exporters advocate for two-year tax exemption    Egyptian Prime Minister follows up on efforts to increase strategic reserves of essential commodities    Italy hits Amazon with a €10m fine over anti-competitive practices    Environment Ministry, Haretna Foundation sign protocol for sustainable development    After 200 days of war, our resolve stands unyielding, akin to might of mountains: Abu Ubaida    World Bank pauses $150m funding for Tanzanian tourism project    China's '40 coal cutback falls short, threatens climate    Swiss freeze on Russian assets dwindles to $6.36b in '23    Amir Karara reflects on 'Beit Al-Rifai' success, aspires for future collaborations    Ministers of Health, Education launch 'Partnership for Healthy Cities' initiative in schools    Egyptian President and Spanish PM discuss Middle East tensions, bilateral relations in phone call    Amstone Egypt unveils groundbreaking "Hydra B5" Patrol Boat, bolstering domestic defence production    Climate change risks 70% of global workforce – ILO    Health Ministry, EADP establish cooperation protocol for African initiatives    Prime Minister Madbouly reviews cooperation with South Sudan    Ramses II statue head returns to Egypt after repatriation from Switzerland    Egypt retains top spot in CFA's MENA Research Challenge    Egyptian public, private sectors off on Apr 25 marking Sinai Liberation    EU pledges €3.5b for oceans, environment    Egypt forms supreme committee to revive historic Ahl Al-Bayt Trail    Debt swaps could unlock $100b for climate action    Acts of goodness: Transforming companies, people, communities    President Al-Sisi embarks on new term with pledge for prosperity, democratic evolution    Amal Al Ghad Magazine congratulates President Sisi on new office term    Egypt starts construction of groundwater drinking water stations in South Sudan    Egyptian, Japanese Judo communities celebrate new coach at Tokyo's Embassy in Cairo    Uppingham Cairo and Rafa Nadal Academy Unite to Elevate Sports Education in Egypt with the Introduction of the "Rafa Nadal Tennis Program"    Financial literacy becomes extremely important – EGX official    Euro area annual inflation up to 2.9% – Eurostat    BYD، Brazil's Sigma Lithium JV likely    UNESCO celebrates World Arabic Language Day    Motaz Azaiza mural in Manchester tribute to Palestinian journalists    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



FACTBOX: Countries resume use of AstraZeneca vaccine, while some lose confidence
Reuters Published in Ahram Online on 25 - 03 - 2021

Many countries are resuming use of the Anglo-Swedish drugmaker's vaccine after the European Medicines Agency (EMA) and the World Health Organization (WHO) said the benefits outweighed the risks following investigations into reports of blood clots.
Fresh data on Thursday showed the AstraZeneca vaccine was 76% effective in preventing symptomatic coronavirus infections in a new analysis of its US trial.
A Ukrainian servicewoman who died two days after taking the Covishield - the vaccine made by AstraZeneca partner Serum Institute of India - had not complained of any ill effects after taking the shot, the health ministry said on Wednesday. A poll on Sunday showed European trust in the vaccine had plunged.
At least 17 countries had suspended or delayed use after reports of hospitalisations with clotting issues and bleeding, while Asia is accelerating inoculations.
UN agency WHO, which has urged inoculations continue, said on Friday that more than 20 million doses of the vaccine had been given to Europeans, with over 27 million doses of Covishield administered in India.
** Below is a list of countries and regions to resume or start using the vaccine after the investigations, in alphabetical order:
Australia:
The pharmaceutical regulator approved on Sunday the local manufacturing of the vaccine by CSL.
Bulgaria:
Resumed inoculations from March 19.
Cyprus:
Cyprus, which suspended the vaccine on March 15, restarted administering it on March 19.
Canada:
Said the vaccine was safe but added a warning to the vaccine's label about rare blood clots.
France:
Medical regulator approved the resumed use of AstraZeneca's vaccine on March 19, but said it should only be given to people aged 55 and older.
Finland:
To resume using the AstraZeneca vaccine from Monday, but will only give it to people aged 65 and over.
Germany:
Resumed administering the AstraZeneca vaccine from March 19.
Indonesia:
Began using the vaccine on Monday after suspending it last week. But the Food and Drug agency has warned against its use on people with blood clotting disorders.
Ireland:
Plans to resume rollout of the vaccine in the coming days for all those aged 18 and over, a committee said on March 19, after suspending it on March 14.
Italy:
Resumed using the vaccine on March 19, and Italians who decline to be inoculated with it will be given an alternative later on.
Latvia:
Also said it would restart administering the shots.
Lithuania:
Restarted administering the vaccine on March 19.
The Netherlands:
The health minister said on March 18 that the country would resume using the vaccine this week.
South Korea:
President Moon Jae-in, 68, plans to get the shot on Tuesday after the government said it could be used on older people.
Spain:
Resumed administering AstraZeneca's coronavirus vaccine from Wednesday, with little sign public enthusiasm has been dented.
Sweden:
Will resume use of the vaccine for people aged 65 and older, its health agency said on Thursday, but keep the pause in place for younger Swedes.
Taiwan:
Premier Su Tseng-chang got the vaccine on Monday as the island began its immunisation campaign.
Thailand:
Began use on March 15, with Prime Minister Prayuth Chan-ocha becoming the first to be inoculated, after Thailand delayed rollout the week before.
Uzbekistan:
Will launch its vaccination campaign with the AstraZeneca vaccine from April 1.
** Below is a list of countries and regions where suspensions continue for now, in alphabetical order:
Austria:
Suspended use of one batch of the vaccine on March 7 after the death of one person and the illness of another.
Cameroon:
Suspended administration of the vaccine it was scheduled to receive on March 20 as part of the global vaccines sharing scheme COVAX, the health ministry said.
Denmark:
Will prolong its suspension of the shot by three weeks pending further investigations after its two-week pause ended on March 25. A local survey indicated that one in three Danes would decline to get the shot.
Georgia:
Has limited the use of the vaccine after a nurse died of anaphylactic shock, news agency TASS reported on March 19.
Iceland:
Suspended vaccine use on March 11.
Norway:
Health authorities said on March 17 it was too soon to say if the vaccine causes blood clots after halting rollout on March 11.
Romania:
Temporarily stopped vaccinating people with one batch of vaccine on March 11.

Clic here to read the story from its source.